Literature DB >> 25946348

Reducing relapse in tuberculosis treatment: is it time to reassess WHO treatment guidelines?

James C Johnston1, Faiz Ahmad Khan2, David W Dowdy3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25946348     DOI： 10.5588/ijtld.15.0224

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN： 1027-3719            Impact factor:   2.373


× No keyword cloud information.
  3 in total

1.  How long will treatment guidelines for TB continue to overlook variability in drug exposure?

Authors:  Morris Muliaditan; Oscar Della Pasqua
Journal:  J Antimicrob Chemother       Date:  2019-11-01       Impact factor: 5.790

2.  Priority-Setting for Novel Drug Regimens to Treat Tuberculosis: An Epidemiologic Model.

Authors:  Emily A Kendall; Sourya Shrestha; Ted Cohen; Eric Nuermberger; Kelly E Dooley; Lice Gonzalez-Angulo; Gavin J Churchyard; Payam Nahid; Michael L Rich; Cathy Bansbach; Thomas Forissier; Christian Lienhardt; David W Dowdy
Journal:  PLoS Med       Date:  2017-01-03       Impact factor: 11.069

3.  Efficacy, safety and prognosis of treating neurological deficits caused by spinal tuberculosis within 4 weeks' standard anti-tuberculosis treatment: A single medical center's experience.

Authors:  Chen-Guang Jia; Jian-Guo Gao; Feng-Sheng Liu; Zhuo Li; Zhao-Liang Dong; Li-Ming Yao; Lian-Bo Wang; Xiao-Wei Yao
Journal:  Exp Ther Med       Date:  2019-11-27       Impact factor: 2.447
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.